What is the impact of SOCS3, IL-35 and IL17 in immune pathogenesis of recurrent pregnancy loss?

dc.contributor.authorOzkan, Zehra Sema
dc.contributor.authorDeveci, Derya
dc.contributor.authorSimsek, Mehmet
dc.contributor.authorIlhan, Fulya
dc.contributor.authorRisvanli, Ali
dc.contributor.authorSapmaz, Ekrem
dc.date.accessioned2026-08-12T17:16:27Z
dc.date.issued2015
dc.departmentFırat Üniversitesi
dc.description.abstractObjective: To investigate the plasma levels of interleukin-4 (IL-4), IL-6, IL-10, tumor necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma), transforming growth factor-beta (TGF-beta), IL-17, IL-35 and suppressor of cytokine signaling 3 (SOCS3) in the women with history of idiopathic recurrent pregnancy loss (RPL) and in the fertile controls. Methods: This study was conducted with 60 idiopathic RPL cases and 40 age-matched fertile controls. Mid-follicular plasma levels of IL-17, IFN-gamma, TNF-alpha, TGF-beta, IL-6, IL-4, IL-10, SOCS3 and IL-35 were assayed by an enzyme linked immunosorbent assay. Results: The mean age of RPL and control cases were 31.6 +/- 0.6 and 32.1 +/- 0.7 years, respectively. While plasma IL-35 and SOCS3 levels of RPL group were significantly lower than that of the control group; IFN-gamma, TNF-alpha, IL-4, IL-6, IL-10, IL-17 and TGF-beta levels of RPL group were significantly higher than that of the control group. The comparison of cytokine ratios between RPL and control groups indicated significantly high TNF-alpha/IL-10, TNF-alpha/IL-4, IFN-gamma/IL-10, IFN-gamma/IL-6 and IFN-gamma/IL-4 ratios in the RPL group. IL-35/IL-17 ratio was significantly low in the RPL group compared to that in the control group. Overstimulation of TNF-alpha presented moderate influence on recurrent miscarriage risk. Conclusion: Decreased SOCS3 and IL-35 plasma levels and increased Th1/Th2 cytokine ratios in RPL cases pointed out the supression of anti-inflammatory process and this supression might play an important role in the pathogenesis of idiopathic RPL.
dc.description.sponsorshipFirat University Scientific Research Foundation
dc.description.sponsorshipThis study was supported by Firat University Scientific Research Foundation.
dc.identifier.doi10.3109/14767058.2014.916676
dc.identifier.endpage328
dc.identifier.issn1476-7058
dc.identifier.issn1476-4954
dc.identifier.issue3
dc.identifier.orcid0000-0001-9185-3663
dc.identifier.orcid0000-0001-7790-1358
dc.identifier.orcid0000-0001-5653-0025
dc.identifier.pmid24762139
dc.identifier.scopus2-s2.0-84923365531
dc.identifier.scopusqualityQ1
dc.identifier.startpage324
dc.identifier.urihttps://doi.org/10.3109/14767058.2014.916676
dc.identifier.urihttps://hdl.handle.net/11508/52290
dc.identifier.volume28
dc.identifier.wosWOS:000350021100017
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofJournal of Maternal-Fetal & Neonatal Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectIL-17
dc.subjectIL-35
dc.subjectrecurrent pregnancy loss
dc.subjectSOCS3
dc.subjectT helper
dc.titleWhat is the impact of SOCS3, IL-35 and IL17 in immune pathogenesis of recurrent pregnancy loss?
dc.typeArticle

Dosyalar